Treatment of Middle East Respiratory Syndrome With a Combination of Lopinavir/Ritonavir and Interferon-Β1b (MIRACLE Trial): Statistical Analysis Plan for a Recursive Two-Stage Group Sequential Randomized Controlled Trial
Trials - United Kingdom
doi 10.1186/s13063-019-3846-x
Full Text
Open PDFAbstract
Available in full text
Date
January 3, 2020
Authors
Publisher
Springer Science and Business Media LLC